Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jaillon

Showing results (91-100 of 195) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1995
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humansC Partovian, E Jacqz-Aigrain, A Keundjian, et al.
Clinical Pharmacology and Therapeutics|May 1, 1992
Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humansC Funck-Brentano, O Bosco, E Jacqz-Aigrain, et al.
British Journal of Clinical Pharmacology|August 1, 1994
Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteersL Dimier-David, N Billon, D Costagliola, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentrationG Cheymol, P Jaillon, B Lecoq, et al.
Journal of the American College of Cardiology|June 1, 1996
Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery diseaseT Madjlessi-Simon, M Mary-Krause, F Fillette, et al.
Journal of Cardiovascular Pharmacology|April 1, 1994
Relationships between acute and chronic beta-blocking effects of bisoprolol in healthy volunteers: a practical approach to predict intensity of beta-blockadeP Jamin, F LeCoz, C Funck-Brentano, et al.
Hepatology (Baltimore, Md.)|March 1, 1988
Effect of vasodilators on hepatic microcirculation: a study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liverP Marteau, F Ballet, Y Chrétien, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1988
Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in manP Menasché, C Pasquier, S Bellucci, et al.
European Heart Journal|March 20, 2003
Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)T Simon, M Mary-Krause, C Funck-Brentano, et al.
Annales De Cardiologie Et D'Angeiologie|June 24, 2006
[Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide]F Liard, J Y Le Heuzey, P Jaillon, et al.
Pageof 20

Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|September 1, 1995
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humansC Partovian, E Jacqz-Aigrain, A Keundjian, et al.
Clinical Pharmacology and Therapeutics|May 1, 1992
Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humansC Funck-Brentano, O Bosco, E Jacqz-Aigrain, et al.
British Journal of Clinical Pharmacology|August 1, 1994
Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteersL Dimier-David, N Billon, D Costagliola, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentrationG Cheymol, P Jaillon, B Lecoq, et al.
Journal of the American College of Cardiology|June 1, 1996
Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery diseaseT Madjlessi-Simon, M Mary-Krause, F Fillette, et al.
Journal of Cardiovascular Pharmacology|April 1, 1994
Relationships between acute and chronic beta-blocking effects of bisoprolol in healthy volunteers: a practical approach to predict intensity of beta-blockadeP Jamin, F LeCoz, C Funck-Brentano, et al.
Hepatology (Baltimore, Md.)|March 1, 1988
Effect of vasodilators on hepatic microcirculation: a study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liverP Marteau, F Ballet, Y Chrétien, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1988
Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in manP Menasché, C Pasquier, S Bellucci, et al.
European Heart Journal|March 20, 2003
Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)T Simon, M Mary-Krause, C Funck-Brentano, et al.
Annales De Cardiologie Et D'Angeiologie|June 24, 2006
[Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide]F Liard, J Y Le Heuzey, P Jaillon, et al.
Pageof 20